SC Filed 2019-04-17 Event — SEC 0001144204-19-019932 →

BioLexis Pte Ltd. → Outlook Therapeutics, Inc. OTLK

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

3,180,446 shares short · -0.0% vs prior

Other 13D/G Filings on Outlook Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-01-22	SCHEDULE	GMS Ventures & Investments	38.60%	12,725,216	view →
2022-07-08	SC	Tenshi Healthcare Pte. Ltd.	—	—	view →
2020-03-24	SC	BioLexis Pte Ltd.	—	—	view →
2020-02-27	SC	BioLexis Pte Ltd.	—	—	view →
2020-01-31	SC	BioLexis Pte Ltd.	—	—	view →
2019-12-30	SC	BioLexis Pte Ltd.	—	—	view →
2019-02-05	SC	BioLexis Pte Ltd.	—	—	view →
2019-01-03	SC	BioLexis Pte Ltd.	—	—	view →
2018-01-05	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by BioLexis Pte Ltd.

Filed	Form	Issuer	Stake	Shares
2022-07-08	SC	Outlook Therapeutics, Inc. OTLK	—	—	view →
2020-03-24	SC	Outlook Therapeutics, Inc. OTLK	—	—	view →
2020-02-27	SC	Outlook Therapeutics, Inc. OTLK	—	—	view →
2020-01-31	SC	Outlook Therapeutics, Inc. OTLK	—	—	view →
2019-12-30	SC	Outlook Therapeutics, Inc. OTLK	—	—	view →
2019-02-05	SC	Outlook Therapeutics, Inc. OTLK	—	—	view →
2019-01-03	SC	Outlook Therapeutics, Inc. OTLK	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →